Edward J Rapp Receives Stock Award at AbbVie Inc (ABBV) — SEC Form 4, Jul 02, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Edward J Rapp CIK 0001171780 |
Director
|
Edward J Rapp at AbbVie Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at AbbVie Inc
| 2026-10-02 | Award | — | View |
| 2026-05-12 | Award | — | View |
| 2026-04-02 | Award | — | View |
| 2026-01-05 | Award | — | View |
| 2025-10-02 | Award | — | View |
Derivative Securities Transactions
Footnotes (2)
- F1
- Director fees credited to a stock equivalent unit account under the director's grantor trust are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. Show more
- F2
- Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Show more
Related filings at AbbVie Inc
Institutional Holders
13F holders · Jun 30, 2026
4,245
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $37.6B
- Vanguard Capital Management Llc $29B
- State Street Corporation $20.8B
5%+ Holders · 13D/G
1 filer
Other insiders at AbbVie Inc
GET /v1/forms/4/0001171780-26-000012
API docs
View Original SEC Filing